Control of Muller glial cell proliferation and activation following retinal injury

Nature Neuroscience

Volumn 3, Issue 9, 2000, Pages 873-880

  Dyer, Michael A ^a   Cepko, Constance L ^a  

^a HOWARD HUGHES MEDICAL INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN D3; GLIAL FIBRILLARY ACIDIC PROTEIN; PROTEIN P27; CDKN1B PROTEIN, MOUSE; CELL CYCLE PROTEIN; CYCLIN DEPENDENT KINASE INHIBITOR 1B; CYCLINE; MICROTUBULE ASSOCIATED PROTEIN; TUMOR SUPPRESSOR PROTEIN;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; CELL ACTIVATION; CELL PROLIFERATION; GENE EXPRESSION; GLIOSIS; IMMUNOHISTOCHEMISTRY; MITOSIS; MOUSE; MUELLER CELL; NERVE CELL LESION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM; RETINA INJURY; RETINA MALFORMATION; ANIMAL; C57BL MOUSE; CELL CULTURE; CELL DIVISION; DIABETIC RETINOPATHY; DOWN REGULATION; GENETICS; GLIA; INJURY; INSTITUTE FOR CANCER RESEARCH MOUSE; METABOLISM; MOUSE MUTANT; NERVE CELL; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; RETINA; RETINA ARTERY; UPREGULATION;

ANIMALS; CELL CYCLE PROTEINS; CELL DIVISION; CELLS, CULTURED; CYCLIN-DEPENDENT KINASE INHIBITOR P27; CYCLINS; DIABETIC RETINOPATHY; DOWN-REGULATION; GLIOSIS; MICE; MICE, INBRED C57BL; MICE, INBRED ICR; MICE, KNOCKOUT; MICROTUBULE-ASSOCIATED PROTEINS; NEUROGLIA; NEURONS; RETINA; RETINAL ARTERY; RETINAL DYSPLASIA; TUMOR SUPPRESSOR PROTEINS; UP-REGULATION;

EID: 0033624560     PISSN: 10976256     EISSN: None     Source Type: Journal    
DOI: 10.1038/78774     Document Type: Article

References (49)

1. Ridet, J. L., Malhotra, S. K., Privat, A. & Gage, F. H. Reactive astrocytes: cellular and molecular cues to biological function. Trends Neurosci 20, 570-577 (1997). [erratum appears in Trends Neurosci. 21, 80, 1998]
2. Wilson, J. X. Antioxidant defense of the brain: a role for astrocytes. Can. J. Physiol. Pharmacol. 75, 1149-1163 (1997).
3. Ide, C. F. et al. Cellular and molecular correlates to plasticity during recovery from injury in the developing mammalian brain. Prog. Brain Res. 108, 365-377 (1996).
4. Streit, W. J., Walter, S. A. & Pennell, N. A. Reactive microgliosis. Prog. Neurobiol. 57, 563-581 (1999).
5. Unger, J. W. Glial reaction in aging and Alzheimer's disease. Microsc. Res. Tech. 43, 24-28 (1998).
6. Streit, W. J. Microglial response to brain injury: a brief synopsis. Toxicol. Pathol. 28, 28-30 (2000).
7. MacLaren, R. E. Development and role of retinal glia in regeneration of ganglion cells following retinal injury. Br. J. Ophthalmol. 80, 458-464 (1996).
8. Sahel, J. A., Albert, D. M. & Lessell, S. [Proliferation of retinal glia and excitatory amino acids]. Ophtalmologie 4, 13-16 (1990).
9. Humphrey, M. F., Constable, I. J., Chu, Y. & Wiffen, S. A quantitative study of the lateral spread of Muller cell responses to retinal lesions in the rabbit. J. Camp. Neurol. 334, 545-558 (1993).
10. Rutka, J. T. & Smith, S. L. Transfection of human astrocytoma cells with glial fibrillary acidic protein complementary DNA: analysis of expression, proliferation, and tumorigenicity. Cancer Res. 53, 3624-3631 (1993).
11. Reichenbach, A. et al. The Muller (glial) cell in normal and diseased retina: a case for single-cell electrophysiology. Ophthalmic Res. 29, 326-340 (1997).
12. Sueishi, K. et al. Endothelial and glial cell interaction in diabetic retinopathy via the function of vascular endothelial growth factor (VEGF). Pol. J. Pharmacol. 48, 307-316 (1996).
13. Amin, R. H. et al. Vascular endothelial growth factor is present in glial cells of the retina and optic nerve of human subjects with nonproliferative diabetic retinopathy. Invest. Ophthalmol. Vis. Sci. 38, 36-47 (1997).
14. Taomoto, M. et al. Retinal degeneration induced by N-methyl-N-nitrosourea in Syrian golden hamsters. Graefes Arch. Clin. Exp. Ophthalmol. 236, 688-695 (1998).
15. Hjelmeland, L. E. & Harvey, A. K. in Progress in Retinal Research, Vol. 7 (eds. Osborn, N. & Chader, G.) 259-281 (Pergamon, New York, 1988).
16. Nork, T. M., Ghobrial, M. W., Peyman, G. A. & Tso, M. O. Massive retinal gliosis. A reactive proliferation of Muller cells. Arch. Ophthalmol. 104, 1383-1389 (1986).
17. Cogan, D. G. Congenital anomalies of the retina. Birth Defects Orig. Artic. Ser. 7, 41-51 (1971).
18. Berger, B., Peyman, G. A., Juarez, C., Mason, G. & Raichand, M. Massive retinal gliosis simulating choroidal melanoma. Can. J. Ophthalmol. 14, 285-290 (1979).
19. Dithmar, S., Holz, F. G. & Volcker, H. E. [Massive reactive gliosis of the retina.] Klin. Monatsbl. Augenheilkd 211, 338-341 (1997).
20. Elledge, S. J. Cell cycle checkpoints: preventing an identity crisis. Science 274, 1664-1672 (1996).
21. Sherr, C. J. & Roberts, J. M. Inhibitors of mammalian G1 cyclin-dependent kinases. Genes Dev. 9, 1149-1163 (1995).
22. Sanchez, I. & Dynlacht, B. D. Transcriptional control of the cell cycle. Curr. Opin. Cell Biol. 8, 318-324 (1996).
23. Yee, A. S., Shih, H. H. & Tevosian, S. G. New perspectives on retinoblastoma family functions in differentiation. Front. Biosci. 3, D532-547 (1998).
24. Hengst, L. & Reed, S. I. Inhibitors of the Cip/Kip family. Curr. Top. Microbiol. Immunol. 227, 25-41 (1998).
25. Nakayama, K. et al. Mice lacking p27(Kip1) display increased body size, multiple organ hyperplasia, retinal dysplasia, and pituitary tumors. Cell 85, 707-720 (1996).
26. Dowling, J. E. The Retina - An Approachable Part of the Brain (Harvard Univ. Press, Cambridge, Massachusetts, 1987).
27. LaBaer, J. et al. New functional activities for the p21 family of CDK inhibitors. Genes Dev. 11, 847-862 (1997).
28. Cheng, M. et al. Thep 21(Cip1) and p27 (Kip1) CDK 'inhibitors'are essential activators of cyclin D-dependent kinases in murine fibroblasts. EMBO J. 18, 1571-1583 (1999).
29. Kiyokawa, H. et al. Enhanced growth of mice lacking the cyclin-dependent kinase inhibitor function of p27(Kip1). Cell 85, 721-732 (1996).
30. Fero, M. L. et al. A syndrome of multiorgan hyperplasia with features of gigantism, tumorigenesis, and female sterility in p27(Kip1)-deficient mice. Cell 85, 733-744 (1996).
31. Rich, K. A., Figueroa, S. L., Zhan, Y. & Blanks, J. C. Effects of Muller cell disruption on mouse photoreceptor cell development. Exp. Eye Res. 61, 235-248 (1995).
32. Cepko, C. L. et al. Lineage analysis using retroviral vectors. Methods 14, 393-406 (1998).
33. Turner, D. L. & Cepko, C. L. A common progenitor for neurons and glia persists in rat retina late in development. Nature 328, 131-136 (1987).
34. Fields-Berry, S. C., Halliday, A. L. & Cepko, C. L. A recombinant retrovirus encoding alkaline phosphatase confirms clonal boundary assignment in lineage analysis of murine retina. Proc. Natl. Acad. Sci. USA 89, 693-697 (1992).
35. Nork, T. M., Wallow, I. H., Sramek, S. J. & Anderson, G. Muller's cell involvement in proliferative diabetic retinopathy. Arch. Ophthalmol. 105, 1424-1429 (1987).
36. Robison, W. G. Jr., Tillis, T. N., Laver, N. & Kinoshita, J. H. Diabetes-related histopathologies of the rat retina prevented with an aldose reductase inhibitor. Exp. Eye Res. 50, 355-366 (1990).
37. Fariss, R. N., Li, Z. Y. & Milam, A. H. Abnormalities in rod photoreceptors, amacrine cells, and horizontal cells in human retinas with retinitis pigmentosa. Am. J. Ophthalmol. 129, 215-223 (2000).
38. Li, Z. Y., Possin, D. E. & Milam, A. H. Histopathology of bone spicule pigmentation in retinitis pigmentosa. Ophthalmology 102, 805-816 (1995).
39. Kimura, H. et al. Cellular response in subretinal neovascularization induced by bFGF-impregnated microspheres. Invest. Ophthalmol. Vis. Sci. 40, 524-528 (1999).
40. Kuhrt, H. et al. Changes in CD44 and ApoE immunoreactivities due to retinal pathology of man and rat. J. Hirnforsch. 38, 223-229 (1997).
41. Birnbach, C. D., Jarvelainen, M., Possin, D. E. & Milam, A. H. Histopathology and immunocytochemistry of the neurosensory retina in fundus flavimaculatus. Ophthalmology 101, 1211-1219 (1994).
42. Madigan, M. C., Penfold, P. L., Provis, J. M., Balind, T. K. & Billson, F. A. Intermediate filament expression in human retinal macroglia. Histopathologic changes associated with age-related macular degeneration. Retina 14, 65-74 (1994).
43. Foisner, R. Dynamic organisation of intermediate filaments and associated proteins during the cell cycle. Bioessays 19, 297-305 (1997).
44. Levine, E. M., Close, J., Fero, M., Ostrovsky, A. & Reh, T. A. p27(Kip1) regulates cell cycle withdrawal of late multipotent progenitor cells in the mammalian retina. Dev. Biol. 219, 299-314 (2000).
45. Matsuoka, S. et al. p57KIP2, a structurally distinct member of the p2 ICIP1 Cdk inhibitor family, is a candidate tumor suppressor gene. Genes Dev. 9, 650-662 (1995).
46. Dyer, M. A. & Cepko, C. L. p57 regulates progenitor cell proliferation and amacrine interneuron development in the mouse retina. Development (in press).
47. Morrow, E. M., Belliveau, M. J. & Cepko, C. L. Two phases of rod photoreceptor differentiation during rat retinal development. J. Neurosci. 18, 3738-3748 (1998).
48. Cepko, C. L., Fields-Berry, S., Ryder, E., Austin, C. & Golden, J. Lineage analysis using retroviral vectors. Curr. Top. Dev. Biol. 36, 51-74 (1998).
49. Sahel, J. A. et al. Mitogenic effects of excitatory amino acids in the adult rat retina. Exp. Eye Res. 53, 657-664 (1991).